Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,212) with videos related to
Page
of 122
Sort By:
British Journal of Pharmacology
|
December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors
Stephen P H Alexander, John A Cidlowski, Eamonn Kelly, et al.
The Annals of Thoracic Surgery
|
December 24, 2013
Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery
Ralf E Harskamp, John H Alexander, Phillip J Schulte, et al.
American Heart Journal
|
February 16, 2018
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
David Kopin, W Schuyler Jones, Matthew W Sherwood, et al.
Occupational and Environmental Medicine
|
September 10, 2015
Occupational ionising radiation and risk of basal cell carcinoma in US radiologic technologists (1983-2005)
Terrence Lee, Alice J Sigurdson, Dale L Preston, et al.
Radiation Research
|
November 1, 2014
Radiation organ doses received in a nationwide cohort of U.S. radiologic technologists: methods and findings
Steven L Simon, Dale L Preston, Martha S Linet, et al.
British Journal of Pharmacology
|
March 2, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Andreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 19, 2023
Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors
G S Ray, P Werth, J H Alexander, et al.
JAMA Network Open
|
November 1, 2024
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial
François M Carrier, Howard A Cooper, Gerard T Portela, et al.
British Journal of Pharmacology
|
February 19, 2025
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
Stavros Topouzis, Andreas Papapetropoulos, Steve P H Alexander, et al.
Cardiovascular Diabetology
|
March 16, 2018
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
Julio Rosenstock, Vlado Perkovic, John H Alexander, et al.
Page
of 122
Search research articles
Search
Showing results (1041-1050 of 1,212) with videos related to
Sort By:
Page
of 122
British Journal of Pharmacology
|
December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors
Stephen P H Alexander, John A Cidlowski, Eamonn Kelly, et al.
The Annals of Thoracic Surgery
|
December 24, 2013
Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery
Ralf E Harskamp, John H Alexander, Phillip J Schulte, et al.
American Heart Journal
|
February 16, 2018
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
David Kopin, W Schuyler Jones, Matthew W Sherwood, et al.
Occupational and Environmental Medicine
|
September 10, 2015
Occupational ionising radiation and risk of basal cell carcinoma in US radiologic technologists (1983-2005)
Terrence Lee, Alice J Sigurdson, Dale L Preston, et al.
Radiation Research
|
November 1, 2014
Radiation organ doses received in a nationwide cohort of U.S. radiologic technologists: methods and findings
Steven L Simon, Dale L Preston, Martha S Linet, et al.
British Journal of Pharmacology
|
March 2, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Andreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 19, 2023
Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors
G S Ray, P Werth, J H Alexander, et al.
JAMA Network Open
|
November 1, 2024
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial
François M Carrier, Howard A Cooper, Gerard T Portela, et al.
British Journal of Pharmacology
|
February 19, 2025
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
Stavros Topouzis, Andreas Papapetropoulos, Steve P H Alexander, et al.
Cardiovascular Diabetology
|
March 16, 2018
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
Julio Rosenstock, Vlado Perkovic, John H Alexander, et al.
Page
of 122